Cerebral amino acid transport in vitro. IV. The effect of inhibitors on exit from brain slices.
D000438:Alcohols / Q000494:pharmacology; D000621:Aminoisobutyric Acids / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism*; D002729:Chloromercuribenzoates / Q000494:pharmacology; D002746:Chlorpromazine / Q000494:pharmacology; D003042:Cocaine / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D000431:Ethanol / Q000494:pharmacology; D066298:In Vitro Techniques; D008239:Lysine / Q000378:metabolism*; D051379:Mice; D010100:Oxygen / Q000494:pharmacology; D010695:Phlorhizin / Q000494:pharmacology; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011526:Protoveratrines / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012964:Sodium / Q000494:pharmacology; D014703:Veratrum / Q000494:pharmacology
D000438:Alcohols; D000621:Aminoisobutyric Acids; D002729:Chloromercuribenzoates; D003486:Cyanides; D004140:Dinitrophenols; D011526:Protoveratrines; D000431:Ethanol; D012110:Reserpine; D012964:Sodium; D010695:Phlorhizin; D003042:Cocaine; D008239:Lysine; D010100:Oxygen; D002746:Chlorpromazine